weight loss – Dr. Barry Dworkin

Minimally invasive sleeve gastroscopy weight loss procedure being used at Royal Alexandria Hospital

May 29, 2026

Medical Mythbusting Commentary for May 29, 2026 Source:New weight loss procedure at Royal Alexandra Hospital being hailed a ‘game-changer’ Reference:Endoscopic sleeve gastroplasty (ESG), GLP-1 receptor agonists, and bariatric surgery each offer distinct risk-benefit profiles, and the optimal choice depends on obesity class, patient preferences, comorbidities, and willingness to commit to long-term pharmacotherapy. Below is a…
House Calls, #1007, March 22, 2026: Keep your hands to yourself!

March 22, 2026

An opinion piece written by Dr. Phoebe Friesen, Director of the Medical Ethics and Health Law course at McGill’s medical school in this week’s Toronto Star discusses the unethical practice of medical students performing pelvic exams on anesthetized/unconscious surgical patients without explicit consent to do so. This is a practice that was banned by the…
New medication in the research pipeline designed to improve upon the efficacy of semaglutide and tirzepatide (Ozempic and Mounjaro) and mitigate side effect profile. Still years to go.

September 11, 2025

Medical Mythbusting Commentary for September 11, 2025 Source:Scientists create new drug that could be the ‘next Ozempic’… it’s twice as effective without nasty side effects
In an act that signifies panic mode, processed food manufacturers like Nestle are launching products directed towards people who are using weight-loss medications as their collective reduction in appetite is biting into sales.

December 24, 2024

Medical Mythbusting Commentary for December 24, 2024 Source:Nestle launches protein shots for U.S. weight-loss drug users
Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.

November 28, 2024

Medical Mythbusting Commentary for November 28, 2024 Source:Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
How various treatments and strategies influence the physiology of the weight-loss plateau

April 23, 2024

Medical Mythbusting Commentary for April 24, 2024 Source:Here’s when your weight loss will plateau, according to science Reference:Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery
Sunday House Call, #909, January 14, 2024: How health insurance company wanna-be-doctor bean counter’s medication-coverage decisions interfere with therapeutic management and has had a deleterious effect on (my) patients’ health outcomes.

January 14, 2024

I talked about this before yet this continues to be a major issue in that evidence-based medicine is being thwarted by insurance companies’ decision to not provide Semaglutide (Ozempic) for the treatment and management of obesity. It is having a deleterious effect both from a mental and physical health perspective on my patients. Wasn’t the…
Could a vibrating, ingestible capsule help treat obesity? Not likely due to logistical, physiological, lifestyle factors, and whether animal models are transferable to humans.

January 3, 2024

Medical Mythbusting Commentary for January 3, 2024 Source:Could a vibrating, ingestible capsule help treat obesity? Reference:A vibrating ingestible bioelectronic stimulator modulates gastric stretch receptors for illusory satiety
TikTokers tout berberine as ‘nature’s Ozempic.’ There is little to no evidence to support this claim.

June 28, 2023

Medical Mythbusting Commentary for June 28, 2023 Source:TikTokers tout berberine as ‘nature’s Ozempic.’ Here’s why doctors say it’s not